Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 85
Filter
1.
Med. infant ; 29(1): 17-22, Marzo 2022. Tab, ilus
Article in Spanish | LILACS, UNISALUD, BINACIS | ID: biblio-1366851

ABSTRACT

Objetivo: evaluar la efectividad de la técnica de conteo de grasas y ajuste de enzimas pancreáticas en un grupo de pacientes con insuficiencia pancreática secundaria a fibrosis quística (FQ). Materiales y métodos: En un grupo de pacientes con FQ, sin otra patología asociada, mayores de 1 año, con >10 000 UKD (unidades por kilo por día) de lipasa; se realizó educación y aplicación de técnica de conteo de grasas con ajuste enzimático, solicitando Van de Kamer y registro alimentario de 5 días durante la recolección de la muestra con un intervalo de 3 meses entre ambas determinaciones. Se evaluó la efectividad de la misma y las dosis de enzimas utilizadas mediante el porcentaje de excreción grasa (PEG), así como las variaciones en la cantidad de enzimas utilizadas y la ganancia de peso. Los datos se registraron en RED Cap (Research Electronic Data Capture) y se analizaron mediante Stata 12. Resultados: De un total de 21 pacientes, 16 completaron la intervención. El 50% presentó un índice de masa corporal (IMC) mayor del Plo 25 antes y después, un 87% alcanzó adecuación calórica mayor del 120% de la ingestas diarias recomendadas (RDA) al final, logrando un aumento promedio de z score de peso de 0,28 con una media inicial de 17 kg y final de 18,2 kg. En cuanto a la media del requerimiento enzimático fue de 14 800 UKD antes y 10 145 UKD después (z=0,002), asimismo el porcentaje de excreción grasa (PEG) tuvo una disminución del 38% (p=0,1705). Conclusiones: La implementación de la técnica de conteo de grasas y ajuste enzimático, podría ser una estrategia válida para aquellos pacientes con FQ que tienen dosis altas de enzimas e inadecuada ganancia de peso (AU)


Objective: To evaluate the effectiveness of the fat counting technique and pancreatic enzyme adjustment in a group of patients with pancreatic insufficiency secondary to cystic fibrosis (CF). Materials and methods: A group of patients with CF without other associated diseases, older than 1 year of age, lipase dose >10 000 UKD (units per kilo per day), received education on the fat counting technique with enzyme adjustment followed by its implementation of the intervention. Van de Kamer was requested and a 5-day food record was kept during the sample collection with an interval of 3 months between both measurements. The effectiveness of the technique and the enzyme doses used were evaluated based on the percentage of fat excretion (PFE), as well as the variations in the amount of enzymes used and weight gain. Data were recorded in RED Cap (Research Electronic Data Capture) and analyzed using Stata 12. Results: Of a total of 21 patients, 16 completed the intervention. Fifty percent had a body mass index (BMI) greater than Plo 25 before and after the intervention; 87% had achieved a caloric increase greater than 120% of the recommended daily intake (RDA) at the end of the study and an average increase in weight z score of 0.28 with an initial mean of 17 kg and a final mean of 18.2 kg. Mean enzyme requirement was 14 800 UKD before and 10 145 UKD after the intervention (z=0.002). PFE decreased by 38% (p=0.1705). Conclusions: The implementation of the technique of fat counting and enzyme adjustment may be a valid strategy for CF patients with high enzyme doses and inadequate weight gain. (AU)


Subject(s)
Infant , Child, Preschool , Child , Adolescent , Pancreas/enzymology , Exocrine Pancreatic Insufficiency , Dietary Fats/administration & dosage , Cystic Fibrosis/diet therapy , Exocrine Glands/abnormalities , Enzyme Replacement Therapy
2.
Bol. latinoam. Caribe plantas med. aromát ; 20(3): 226-243, may. 2021. ilus, tab
Article in English | LILACS | ID: biblio-1342815

ABSTRACT

Several species of the Myrcia genus have been used in folk medicine to treat diabetes. Therefore, the aim of this work was to investigate the inhibitory activity of α-glucosidase and pancreatic lipase in the crude extract (EBF) and in the ethyl acetate fraction (FFA) of Myrcia hatschbachii, as well as to identify isolated phenolic compounds and to evaluate the antioxidant property and preliminary in vitro toxicity against Artemia salina. EBF (IC50: 3.21 µg/mL) and FFA (IC50: 1.14 µg/mL) showed inhibitory activity superior to acarbose (IC50: 193.65 µg/mL). In addition, they showed inhibitory effects of pancreatic lipase (IC50: 556.58 µg/mL for EBF and 532.68 µg/mL for FFA), antioxidant potential, absence of preliminary toxicity and presence of gallic andellagic acids in FFA. The relevant results in the inhibition of α-glucosidase and pancreatic lipase motivate new studies for the development of herbal medicines that assist in the treatment of diabetic patients.


Varias especies del género Myrcia se han utilizado en la medicina popular para tratar la diabetes. Por lo tanto, el objetivo de este trabajo fue investigar la actividad inhibitoria de la α-glucosidasa y la lipasa pancreática en el extracto crudo (EBF) y en la fracción de acetato de etilo (FFA) de Myrcia hatschbachii, así como identificar compuestos fenólicos aislados y evaluar la propiedad antioxidante y toxicidad in vitro preliminar contra Artemia salina. EBF (IC50: 3.21 µg/mL) y FFA (IC50: 1.14 µg/mL) mostraron una actividad inhibitoria superior a la acarbosa (IC50: 193.65 µg/mL). Además, mostraron efectos inhibitorios de la lipasa pancreática (IC50: 556.58 µg/mL para EBF y 532.68 µg/mL para FFA), potencial antioxidante, ausencia de toxicidad preliminar y presencia de ácidos gálico y elágico en FFA. Los resultados relevantes en la inhibición de la α-glucosidasa y la lipasa pancreática motivan nuevos estudios para el desarrollo de medicamentos a base de hierbas que ayudan en el tratamiento de pacientes diabéticos.


Subject(s)
Plant Extracts/pharmacology , Myrtaceae/chemistry , Glycoside Hydrolase Inhibitors/pharmacology , Lipase/drug effects , Antioxidants/pharmacology , Pancreas/enzymology , Phenols/analysis , X-Ray Diffraction , In Vitro Techniques , Plant Extracts/toxicity , Plant Extracts/chemistry , Free Radical Scavengers , Complex Mixtures , Ellagic Acid , Gallic Acid , Antioxidants/chemistry
3.
Article in English | IMSEAR | ID: sea-163225

ABSTRACT

Aims: To highlight whether metabolites of Alcaligenes faecalis BW1 extract can be administered orally for their possible antimycobacterial effects. Study Design: Study of the influence of certain parameters on the extract of Alcaligenes faecalis by using either discs or well diffusion methods against M. smegmatis. Place and duration of study: Laboratory of Microbial Biotechnology, Department of Biology, Faculty of Sciences and Technical, University Sidi Mohamed Ben Abdellah, BP 2202, Road of Immouzer, Fez, Morocco. From April to August, 2012. Methodology: The impact of acidic pH of gastric juice, bile, hydrogen peroxide, pancreatic enzymes and lysozyme on the antimycobacterial activity of Alcaligenes faecalis BW1 extract was evaluated by agar diffusion method. Detection whether or not antibacterial metabolites having a synergistic effect with rifampicin against M. smegmatis was also explored. Results: Antibacterial metabolites of Alcaligenes faecalis BW1 extract resist to the action of gastric pH, gallbladder bile and hydrogen peroxide. In addition, they are not affected by pancreatic enzymes and lysozyme. Moreover, they have a synergistic effect with rifampicin against M. smegmatis. Conclusion: Anti-mycobacterial metabolites of Alcaligenes faecalis BW1 extract are compatible with rifampicin and could be administered orally as antitubercular agents after their purification, identification in further work.


Subject(s)
Alcaligenes faecalis/physiology , Anti-Infective Agents/physiology , Anti-Infective Agents/pharmacokinetics , Bacteria/physiology , Bacteria/pharmacokinetics , Bile/chemistry , Cell Extracts/isolation & purification , Gastric Juice/chemistry , Isoenzymes/chemistry , Pancreas/chemistry , Pancreas/enzymology , Sensitivity and Specificity
4.
Gut and Liver ; : 563-568, 2014.
Article in English | WPRIM | ID: wpr-91769

ABSTRACT

BACKGROUND/AIMS: To determine the nutritional markers important for assessing the degree of pancreatic insufficiency due to chronic pancreatitis in routine clinical practice. METHODS: A total of 137 patients with chronic pancreatitis were followed up for more than 1 year. They were divided into two groups: a pancreatic diabetes mellitus (DM) group, consisting of 47 patients undergoing medical treatment for DM of pancreatic origin, and a nonpancreatic DM group, consisting of 90 other patients (including 86 patients without DM). Serum albumin, prealbumin, total cholesterol, cholinesterase, magnesium, and hemoglobin were compared between the two groups. RESULTS: The total cholesterol was significantly lower in the pancreatic than the nonpancreatic DM group (164 mg/dL vs 183 mg/dL, respectively; p=0.0028). Cholinesterase was significantly lower in the former group (263 U/L vs 291 U/L, respectively; p=0.016). Among the 37 patients with nonalcoholic pancreatitis, there was no difference in the cholinesterase levels between the pancreatic and nonpancreatic (296 U/L vs 304 U/L, respectively; p=0.752) DM groups, although cholesterol levels remained lower in the former (165 mg/dL vs 187 mg/dL, respectively; p=0.052). CONCLUSIONS: Cholinesterase levels are possibly affected by concomitant alcoholic liver injury. The total cholesterol level should be considered when assessing pancreatic insufficiency due to chronic pancreatitis.


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Cholesterol/blood , Cholinesterases/blood , Diabetes Mellitus, Type 2/complications , Exocrine Pancreatic Insufficiency/blood , Follow-Up Studies , Liver Cirrhosis, Alcoholic/blood , Nutritional Status , Pancreas/enzymology , Pancreatitis, Alcoholic/blood , Pancreatitis, Chronic/blood , Serum Albumin/analysis
5.
Article in English | WPRIM | ID: wpr-216473

ABSTRACT

IgG4-related disease (IgG4-RD) is characterized by a systemic involvement of tumor-like lesions with IgG4-positive plasmacytes. We experienced a case of IgG4-RD developed in a patient with bronchial asthma (BA) and chronic rhinosinusitis (CRS). A 55-yr-old female patient with BA and CRS complained of both eyes and neck swelling as well as a recurrent upper respiratory infection in recent 1 yr. The serum levels of IgG4, creatinine, and pancreatic enzymes were elevated. A biopsy of the submandibular gland showed an abundant infiltration of IgG4-positive plasmacytes. Her symptoms remarkably improved after the treatment of a systemic steroid that has been maintained without recurrence. We report a rare case of IgG4-RD developed in a patient with BA and CRS.


Subject(s)
Female , Humans , Middle Aged , Asthma/complications , Chronic Disease , Creatinine/blood , Immunoglobulin G/blood , Pancreas/enzymology , Plasma Cells/physiology , Prednisolone/therapeutic use , Republic of Korea , Rhinitis/complications , Sinusitis/complications , Submandibular Gland/pathology , Tomography, X-Ray Computed
6.
Pakistan Journal of Pharmaceutical Sciences. 2013; 26 (5): 907-913
in English | IMEMR | ID: emr-138408

ABSTRACT

Carboxypeptidase-B [E.C 3.4.17.2] catalyzes the hydrolysis of peptides and esters at C-terminus of arginine and lysine residues. Our study describes the large scale purification, N-terminal sequence analysis and physiochemical properties of pancreatic enzyme from river buffalo [Bubalus bubalis]. The enzyme was purified up to 71 folds by anionexchange chromatography with 21% final recovery. Purified enzyme displayed two bands on SDS-PAGE with molecular weights of 9 kDa and 26 kDa respectively, the N-terminal sequence of later was EFLDKLDFYV. The enzyme has shown optimum activity at pH 9.0 and 40°C. The K[M], Kcat and K[cat]/K[M] values of purified carboxypeptidase-B with Hippuryl-LArg are 30 micro M, 72sec[-1] and 2.4x10[5] M[-1] sec[-1] respectively. A computer based model for the structure of enzyme was proposed by chromatographic studies of component fragments and N-terminal sequence. The enzyme purified in the present study was free of carboxypeptidase A and endoprotease contamination. It was efficiently used in the processing of recombinant buffalo proinsulin, in combination with trypsin. Activation of proinsulin was monitored by MALDI-TOF analysis of peptides before and after the action of enzymes


Subject(s)
Animals , Pancreas/enzymology , Proinsulin/metabolism , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Structure-Activity Relationship , Substrate Specificity , Temperature , Kinetics , Models, Molecular , Molecular Sequence Data , Molecular Weight , Chromatography, Ion Exchange , Computer Simulation , Buffaloes
7.
Indian J Biochem Biophys ; 2012 Feb; 49(1): 55-62
Article in English | IMSEAR | ID: sea-140219

ABSTRACT

The antihyperglycemic, antihyperlipidemic and antioxidative properties of hydroethanolic extract of Butea monosperma bark were investigated in alloxan-induced diabetic mice. Alloxan administration resulted in higher blood glucose level and reduced hepatic glycogen content as compared to normal animals. Besides, serum lipid profile parameters such as total cholesterol (TC), triglyceride (TG), low density lipoprotein (LDL) and very low density lipoprotein (VLDL) cholesterol were also found to be significantly elevated, whereas the level of high density lipoprotein (HDL) cholesterol was markedly reduced in diabetic animals. Oxidative damage in the tissues of diabetic mice was evidenced by a marked increase in the level of thiobarbituric acid reactive substances (TBARS), distinct decrease in reduced glutathione (GSH) content and declined activity of antioxidant enzymes, such as superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px). The daily treatment of diabetic animals with crude extract of B. monosperma bark (300 mg kg-1) for 45 days significantly lowered blood glucose level and elevated hepatic glycogen content, bringing the values close to those observed in normal control and glibenclamide-treated diabetic mice. Furthermore, the level of various lipid profile parameters was also reversed towards normal. TBARS and GSH also restored towards normal and the declined activity of antioxidant enzymes in diabetic animals was also normalized in crude extract administered mice, thus indicating the antioxidant efficacy of the drug in diabetes-induced oxidative damage. Significant antihyperglycemic and antioxidant potential of the crude extract of B. monosperma bark indicated that it may find use in the management of diabetes and resultant oxidative stress.


Subject(s)
Alloxan , Animals , Antioxidants/pharmacology , Blood Glucose/drug effects , Blood Glucose/metabolism , Body Weight/drug effects , Butea , Diabetes Mellitus, Experimental/drug therapy , Hypoglycemic Agents/pharmacology , Kidney/drug effects , Kidney/enzymology , Kidney/metabolism , Lipids/blood , Liver/drug effects , Liver/enzymology , Liver/metabolism , Mice , Oxidative Stress/drug effects , Pancreas/drug effects , Pancreas/enzymology , Pancreas/metabolism , Phytotherapy , Plant Bark , Plant Extracts/pharmacology
8.
Indian J Biochem Biophys ; 2008 Aug; 45(4): 256-62
Article in English | IMSEAR | ID: sea-27626

ABSTRACT

Phospholipase A2 (PLA2) is a ubiquitous enzyme that specifically catalyzes hydrolysis of membrane phospholipids to produce lysophospholipids and free fatty acid, namely arachidonic acid, which provides substrate for eicosanoids biosynthesis. Thus, the compounds inhibiting PLA2 have been implicated as potential therapeutic agents in treatment of inflammation related diseases. Plant and marine organisms serve as sources of compounds that act as potential therapeutic agents for treatment of various diseases. The present study reveals the relationship between the structure and function of the medicinally important herbal compounds (acalyphin, chlorogenic acid, stigmasterol, curcumin and tectoridin) and marine compounds (gracilin A and aplysulphurin A). To understand the binding mechanisms of these compounds, molecular modeling studies has been performed with Russell's viper and bovine pancreatic PLA2 as target molecules using molecular operating environment (MOE) software. These compounds show favorable interactions with the amino acid residues at the active site of Russell's viper and bovine pancreatic PLA2, thereby substantiating their proven efficacy as anti-inflammatory compounds and antidotes.


Subject(s)
Animals , Binding Sites , Enzyme Inhibitors/chemistry , Models, Molecular , Oligopeptides/chemistry , Pancreas/enzymology , Phospholipases A2/antagonists & inhibitors , Plant Extracts/chemistry , Daboia , Viper Venoms/chemistry
10.
Article in English | WPRIM | ID: wpr-634579

ABSTRACT

A stable and reliable infected necrotizing pancreatitis (INP) model in rats was established in order to study the pathophysiological mechanism and pathological development rule of INP and explore the new therapeutic methods for the diseases. Forty-six SD rats were randomly divided into 5 groups. The animals in group A received the injection of 5% sodium taurocholate into the pancreatic duct and those in group B underwent that of E. coli into the pancreatic duct. The rats in groups C, D and E were subjected to the injection of 5% sodium taurocholate in combination with different concentrations of E. coli (10(3), 10(4), 10(5)/mL, respectively) into the pancreatic duct. The dose of injection was 0.1 mL/100 g and the velocity of injection was 0.2 mL/min in all the 5 groups. Eight h after the injection, the survival rate of animals was recorded and the surviving rats were killed to determine the serum content of amylase and perform pathological examination and germ cultivation of the pancreatic tissue. The results showed that acute necrotizing pancreatitis model was induced by injection of 5% sodium taurocholate into the pancreatic duct. The positive rate of germ cultivation in group A was 12.5%. The acute necrotizing pancreatitis model was not induced by injection of E. coli into the pancreatic duct and the positive rate of germ cultivation in group B was 0. The INP model was established in groups C to E. The positive rate of germ cultivation was 60%, 100% and 100% and 8-h survival rate 100%, 100% and 70% in groups C, D and E, respectively. It was concluded that a stable and reliable model of INP was established by injection of 5% sodium taurocholate in combination with 10(4)/mL E. coli into the pancreatic duct with a dose of 0.1 mL/100 g and a velocity of 0.2 mL/min. The pathogenesis of INP might be that the hemorrhage and necrosis of pancreatic tissue induced by sodium taurocholate results in weakness of pancreatic tissue in fighting against the germs. Meanwhile, the necrotic pancreatic tissue provides a good proliferative environment for the germs.


Subject(s)
Cholagogues and Choleretics/pharmacology , Disease Models, Animal , Escherichia coli/metabolism , Injections, Intraperitoneal , Pancreas/enzymology , Pancreas/microbiology , Pancreatic Ducts/enzymology , Pancreatic Ducts/microbiology , Pancreatitis, Acute Necrotizing/chemically induced , Pancreatitis, Acute Necrotizing/microbiology , Rats, Sprague-Dawley , Taurocholic Acid/pharmacology , Time Factors
11.
Acta cir. bras ; 22(5): 366-371, Sept.-Oct. 2007. ilus, graf, tab
Article in English | LILACS | ID: lil-463461

ABSTRACT

PURPOSE: To develop an experimental model of severe acute pancreatitis in rabbits through a pancreatic ductal injection of sodium taurocholate. METHODS: Twenty-four albino rabbits of the New Zealand lineage were distributed into four groups of six animals (A, B, C and S). The rabbits of three experimental groups (A, B and C) were submitted to a laparatomy and received a pancreatic ductal injection of 1ml/kg sodium taurocholate 5 percent. Also, they were submitted to further laparatomies after 4h, 8h and 12h, respectively. The control group (S) was subdivided into two groups of three animals: in subgroup S1 only the pancreatic duct catheterization was performed whereas in subgroup S2 the pancreatic duct catheterization as well as an injection of 1ml/kg physiologic solution 0.9 percent were carried out. After 12 hours, the rabbits were evaluated. In the re-intervention, blood was collected to determine the amylasemia and a pancreatectomy was carried out to investigate interstitial infiltration, steatonecrosis and necrosis of the organ, using an optical microscope. RESULTS: There was an elevation of amylase in all groups thus proving the existence of acute pancreatitis. The size of the interlobular septum increased progressively with a greater variation between group S1 (0.13) and group C (0. 53) (p=0.035). While all the animals in group A exhibited focal cellular necrosis, it was more intense in the rabbits of group B and culminated with a high proportion of severe pancreatic necrosis in group C animals. The difference in the intensity of cellular necrosis showed statistic significance (p=0.001). CONCLUSION: The proposed experimental model demonstrated its reproducibility and effectiveness in producing severe acute pancreatitis in rabbits.


OBJETIVO: Desenvolver modelo experimental de pancreatite aguda grave em coelhos por meio da injeção de taurocolato de sódio no ducto pancreático. MÉTODOS: Vinte e quatro coelhos albinos da linhagem Nova Zelândia foram distribuídos em quatro grupos de seis animais (A, B, C e S). Os coelhos dos três grupos experimentais (A, B e C) foram submetidos a laparotomia e injetou-se taurocolato de sódio a 5 por cento, 1ml/Kg no ducto pancreático. Realizou-se nova laparotomia, respectivamente, após 4h, 8h e 12h. No grupo controle (S), subdividido em dois grupos de três animais, foi realizada no subgrupo S1 apenas cateterização do ducto pancreático e no subgrupo S2 cateterização do ducto pancreático e injeção de solução fisiológica 0,9 por cento, 1ml/Kg. Estes animais foram reavaliados após 12 horas. Na reintervenção coletou-se sangue para determinação da amilasemia e realizou-se pancreatectomia para análise histológica do infiltrado intersticial, da esteatonecrose e da necrose do órgão. RESULTADOS: Houve elevação da amilase em todos os grupos, demonstrando a presença da pancreatite aguda. O tamanho do septo interlobular aumentou progressivamente, observando-se maior diferença entre os grupos S1 (0,13) e C (0,53) (p=0,035). Todos os animais do grupo A apresentaram necrose celular focal que se tornou mais intensa nos coelhos do grupo B, culminando com o predomínio de necrose pancreática acentuada nos animais do grupo C. A diferença na intensidade da necrose celular apresentou significância estatística (p=0,001). CONCLUSÃO: O modelo experimental proposto se mostrou reprodutível e efetivo em provocar pancreatite aguda grave em coelhos.


Subject(s)
Animals , Female , Rabbits , Cholagogues and Choleretics , Pancreatitis/chemically induced , Taurocholic Acid , Acute Disease , Analysis of Variance , Amylases/blood , Injections , Models, Animal , Necrosis/etiology , Pancreatectomy , Pancreas/enzymology , Pancreas/pathology , Pancreas/surgery , Pancreatic Ducts/surgery , Pancreatitis/complications , Research Design
13.
Rev. invest. clín ; 59(2): 124-129, mar.-abr. 2007. ilus
Article in Spanish | LILACS | ID: lil-632366

ABSTRACT

The relation between steroid hormones and pancreatic function has been poorly discussed and not very well understood. In general, there is a lack of recognition among the scientific community about the importance of steroids in pancreatic function (current paradigm). In the present article we present basic, as well as clinic and epidemiologic data that demonstrate steroid synthesis and steroid biotransformation by pancreatic tissue, how exocrine and endocrine functions are modulated by steroids, the gender specific frequency and behavior of some tumors and the use of synthetic steroids and steroid action antagonists as therapeutic agents. With the available information it is possible to establish that: 1. Pancreatic tissue synthesize and transform steroid hormones. 2. Pancreatic tissue respond to steroid hormones and express steroid specific receptor molecules. 3. Some endocrine functions such as insulin synthesis and release are modulated by steroids. 4. Tumor growth is modulated by steroids and anti-steroid drugs. This set of data creates a new paradigm for the holistic study of pancreas and opens new research fields. The application of this new paradigm might result in an increase in the knowledge of pancreatic physiology, in the design of new and better diagnostic methods and eventually in the design of more effective medical treatments for the pancreatic cancers.


La relación de las hormonas esteroides con el páncreas ha sido muy poco explorada y comprendida y no se concede en general que exista una interacción relevante entre su función y los esteroides endógenos o exógenos (paradigma actual). En esta revisión se presentan datos de modelos experimentales y de estudios clínicos y epidemiológicos que demuestran que existe una clara relación entre la biotransformación y el efecto de las hormonas esteroides y la fisiopatología del páncreas. Con la información disponible se puede establecer que: 1. El páncreas es un órgano que sintetiza y transforma hormonas esteroides. 2. Que expresa receptores específicos para este tipo de substancias. 3. Que algunas de sus funciones como la síntesis y liberación de la insulina pueden ser modulados por la acción de esteroides gonadales. 4. Que el crecimiento tumoral puede ser inducido o frenado por la acción de esteroides y antiesteroides. Estas relaciones establecen un nuevo paradigma en el estudio de la fisiopatología del páncreas y abren nuevas líneas de investigación para el avance del conocimiento y su eventual aplicación clínica.


Subject(s)
Animals , Female , Humans , Male , Rats , Hormones/physiology , Models, Biological , Pancreas/physiology , Steroids/physiology , Adenocarcinoma/drug therapy , Adenocarcinoma/epidemiology , Adenocarcinoma/physiopathology , Antineoplastic Agents, Hormonal/therapeutic use , Gonadal Steroid Hormones/physiology , Insulin , Mammals/physiology , Pancreas/enzymology , Pancreatic Neoplasms/drug therapy , Pancreatic Neoplasms/epidemiology , Pancreatic Neoplasms/physiopathology
14.
Iranian Journal of Diabetes and Lipid Disorders. 2005; 5 (2): 99-108
in Persian | IMEMR | ID: emr-71162

ABSTRACT

Glucokinase serves as a glucose sensor in pancreatic beta-cells and plays a key role in glucose homeostasis and glucose-stimulated insulin secretion [GSIS]. In the present study we examined the effect of glucosamine, a glucokinase inhibitor, on the pancreatic glucokinase and hexokinase activities and on insulin secretion from freshly rat pancreatic islets of Langerhans. Insulin concentration was measured by rat insulin ELISA kit. The pancreatic islets from normal and type 2 diabetic [nSTZ] rats were isolated by collagenase digestion method. Glucose phosphorylation was quantitated by measuring the rate of glucose-6-phosphate formation in the fluorometric assay. Insulin secretion from hand-picked islets was evaluated in static incubation system. Insulin concentration was measured by rat insulin ELISA kit. Our findings demonstrate that glucosamine in a dose dependent manner, reduced glucokinase activity in islet extract, but had no effect on hexokinase activity. The glucose-stimulated insulin secretion was inhibited by glucosamine but it had no effect on the basal insulin secretion. In diabetic rats glucokinase was decreased while the basal insulin secretion and the activity of hexokinase were higher than normals. Based on results obtained from the present study, the assumption could be made that the decrease in the activity of glucokinase of pancreatic islets could be related to the impaired glucose stimulated insulin secretion. The increase in basal insulin secretion of diabetic rats may be due to an increase in pancreatic hexokinase activity


Subject(s)
Animals, Laboratory , Glucokinase , Pancreas/enzymology , Rats , Insulin/metabolism , Islets of Langerhans , Diabetes Mellitus, Type 2 , Diabetes Mellitus, Experimental , Hexokinase
15.
Article in English | IMSEAR | ID: sea-25774

ABSTRACT

Spices have long been recognized for their digestive stimulant action. Several spices are also employed in medicinal preparations against digestive disorders in traditional and Indian systems of medicine. Earlier reports on the digestive stimulant action of spices are largely empirical; only in recent years, this beneficial attribute of spices has been authenticated in exhaustive animal studies. Animal studies have shown that many spices induce higher secretion of bile acids which play a vital role in fat digestion and absorption. When consumed through the diet also spices produce significant stimulation of the activities of pancreatic lipase, amylase and proteases. A few of them also have been shown to have beneficial effect on the terminal digestive enzymes of small intestinal mucosa. Concomitant with such a stimulation of either bile secretion or activity of digestive enzymes by these spices, leading to an accelerated digestion, a reduction in the food transit time in the gastrointestinal tract has also been shown. Thus, the digestive stimulant action of spices seems to be mediated through two possible modes: (i) by stimulating the liver to secrete bile rich in bile acids, components that are vital for fat digestion and absorption, and (ii) by a stimulation of enzyme activities that are responsible for digestion. This review highlights the available information on the influence of spices on the digestive secretions and enzymes.


Subject(s)
Animals , Bile/metabolism , Digestion/physiology , Gastrointestinal Transit/physiology , Humans , Intestinal Secretions/enzymology , Medicine, Traditional , Pancreas/enzymology , Saliva/metabolism , Spices
16.
Bol. Hosp. San Juan de Dios ; 47(1): 29-32, ene.-feb. 2000.
Article in Spanish | LILACS | ID: lil-258139

ABSTRACT

Se da cuenta de un nuevo test de función pancreática exocrina, consistente en la determinación de elastasa 1 en las heces. Este examen tiene mayor sensibilidad y especificidad de los utilizados hasta ahora. La determinación de elastasa 1 en sangre tiene un valor similar a la de amilasa y lipasa, pero su utilidad diagnóstica es más persistente y no tiene resultados falsos positivos derivados de fuentes extrapancreáticas, como ocurre con la amilasa


Subject(s)
Humans , Pancreatic Elastase , Pancreatitis/diagnosis , Pancreatic Function Tests , alpha-Amylases , Amylases , Feces/chemistry , Lipase , Pancreas/enzymology , Sensitivity and Specificity
17.
Article in English | WPRIM | ID: wpr-117534

ABSTRACT

Since GABA and its related enzymes had been determined in beta-cells of pancreas islets, effects of GABA on pancreatic exocrine secretion were investigated in the isolated perfused rat pancreas. GABA, given intra-arterially at concentrations of 3, 10, 30 and 100 microM, did not exert any influence on spontaneous or secretin (12 pM)-induced pancreatic exocrine secretion. However, GABA further elevated cholecystokinin (10 pM)-, gastrin-releasing peptide (100 pM)- or electrical field stimulation-induced pancreatic secretions of fluid and amylase, dose-dependently. The GABA-enhanced CCK-induced pancreatic secretions were completely blocked by bicuculline (10 microM), a GABAA receptor antagonist but not affected by saclofen (10 microM), a GABA(B) receptor antagonist. The enhancing effects of GABA (30 microM) on CCK-induced pancreatic secretions were not changed by tetrodotoxin (1 microM) but partially reduced by cyclo-(7-aminoheptanonyl-Phe-D-Trp-Lys-Thr[BZL]) (10 microM), a somatostatin antagonist. In conclusion, GABA enhances pancreatic exocrine secretion induced by secretagogues, which stimulate enzyme secretion predominantly, via GABA(A) receptors in the rat pancreas. The enhancing effect of GABA is partially mediated by inhibition of islet somatostatin release. GABA does not modify the activity of intrapancreatic neurons.


Subject(s)
Rats , Amylases/metabolism , Animals , Baclofen/pharmacology , Baclofen/analogs & derivatives , Bicuculline/pharmacology , Cholecystokinin/metabolism , Dose-Response Relationship, Drug , Electric Stimulation , gamma-Aminobutyric Acid/pharmacology , GABA Antagonists/pharmacology , Gastrin-Releasing Peptide/metabolism , Hormones/pharmacology , In Vitro Techniques , Pancreas/metabolism , Pancreas/enzymology , Pancreas/drug effects , Receptors, GABA-A/metabolism , Secretin/metabolism , Somatostatin/pharmacology , Tetrodotoxin/pharmacology
19.
Rev. cuba. pediatr ; 68(2): 125-30, mayo-ago. 1996. tab
Article in Spanish | LILACS | ID: lil-184557

ABSTRACT

La mayoria de los pacientes con fibrosis quistica presenta una insuficiencia exocrina de la funcion pancreatica que entrana trastornos digestivos complejos. Se estudian 8 pacientes entre 1 y 12 anos con el diagnostico de fibrosis quistica. Se les realizo enzimas pancreaticas en suero, electroforesis de proteinas y marcadores virales de la hepatitis B y C. Tambien se les efectuo ultrasonido abdominal, gammagrafia esofagica, hepatica y biliar. Las manifestaciones clinicas mas frecuentes fueron la esteatorrea, colicos abdominales y hepatomegalia. Se encontro la lipasa aumentada en suero en 2 pacientes con suficiencia pancreatica y las transaminasas normales en todos ellos. Las manifestaciones hepaticas estuvieron presentes en 3 pacientes y el reflujo gatroesofagico y el prolapso rectal en 2, respectivamente. Se observo que el control terapeutico de estas manifestaciones reportan un buen estado nutricional y mejor calidad de vida


Subject(s)
Humans , Infant, Newborn , Infant , Child, Preschool , Child , Amylases/blood , Blood Protein Electrophoresis , Electrophoresis , Cystic Fibrosis/complications , Liver/enzymology , Iontophoresis , Lipase/blood , Pancreas/enzymology , Sweating , Nutritional Status , Quality of Life
SELECTION OF CITATIONS
SEARCH DETAIL